Abcam PLC

Nasdaq : ABCM

Sells biological reagents and tools for research, drug discovery, and diagnostics.

  • Filed 02-10-2020
  • Set Terms --
  • IPO Date 22-10-2020
  • Lock Up 21-01-2021
Текущая цена
22.6 $
Текущая доходность
29.14 %
Доходность за 1 день торгов
12.86 %
Доходность по итогам
Lock up периода
33.26 %
Рейтинг от IPO.one:
Дата IPO
22-10-2020
Объем размещения
8 945 218
Размер сделки ($M)
157
Диапазон цены
17.5-17.5 $
Цена IPO
17.5 $
Lock Up
21-01-2021
Год основания
1998
Головной офис
Cambridge, United
Веб сайт
Юристы
Davis Polk Latham & Watkins
Аудитор
PwC
Андеррайтер
Morgan Stanley

Описание компании

We are a global life science company focused on identifying, developing and distributing high-quality reagents and tools for our customers at the forefront of life science research. Our products are used by researchers to study biological pathways, which is critical for scientific research, diagnostics and drug discovery. Our mission is to provide life science researchers with highly validated products and services to advance biological research and achieve their goals faster. We do this by continuously innovating and providing our customers with high-quality tools, together with expert customer support. Our product offering includes an extensive portfolio of antibodies and related protein research tools that are fundamental to our customers’ research and experimental workflow. Our customers are primarily scientists and researchers in academic institutions, research institutes and pharmaceutical, biotechnology and diagnostics companies. Headquartered in Cambridge, United Kingdom, we operate across 15 locations around the world, supported by our world-class team of approximately 1,500 employees, including over 200 with PhDs, and have served customers in over 130 countries